JP2017516826A5 - - Google Patents

Download PDF

Info

Publication number
JP2017516826A5
JP2017516826A5 JP2016571095A JP2016571095A JP2017516826A5 JP 2017516826 A5 JP2017516826 A5 JP 2017516826A5 JP 2016571095 A JP2016571095 A JP 2016571095A JP 2016571095 A JP2016571095 A JP 2016571095A JP 2017516826 A5 JP2017516826 A5 JP 2017516826A5
Authority
JP
Japan
Prior art keywords
optionally substituted
groups selected
substituted
ring
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016571095A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017516826A (ja
JP6635949B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2015/050654 external-priority patent/WO2015187089A1/en
Publication of JP2017516826A publication Critical patent/JP2017516826A/ja
Publication of JP2017516826A5 publication Critical patent/JP2017516826A5/ja
Application granted granted Critical
Publication of JP6635949B2 publication Critical patent/JP6635949B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016571095A 2014-06-04 2015-06-04 炎症性および自己免疫性の病気の処置のためのmth1阻害剤 Active JP6635949B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1450681-0 2014-06-04
SE1450681 2014-06-04
PCT/SE2015/050654 WO2015187089A1 (en) 2014-06-04 2015-06-04 Mth1 inhibitors for treatment of inflammatory and autoimmune conditions

Publications (3)

Publication Number Publication Date
JP2017516826A JP2017516826A (ja) 2017-06-22
JP2017516826A5 true JP2017516826A5 (cg-RX-API-DMAC7.html) 2018-06-28
JP6635949B2 JP6635949B2 (ja) 2020-01-29

Family

ID=54767050

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016571095A Active JP6635949B2 (ja) 2014-06-04 2015-06-04 炎症性および自己免疫性の病気の処置のためのmth1阻害剤

Country Status (10)

Country Link
US (2) US10064869B2 (cg-RX-API-DMAC7.html)
EP (1) EP3151833A4 (cg-RX-API-DMAC7.html)
JP (1) JP6635949B2 (cg-RX-API-DMAC7.html)
CN (1) CN106794181A (cg-RX-API-DMAC7.html)
AU (1) AU2015268962A1 (cg-RX-API-DMAC7.html)
CA (1) CA2948601A1 (cg-RX-API-DMAC7.html)
IL (1) IL249223A0 (cg-RX-API-DMAC7.html)
RU (1) RU2016151390A (cg-RX-API-DMAC7.html)
SG (1) SG11201609981RA (cg-RX-API-DMAC7.html)
WO (1) WO2015187089A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20181109T1 (hr) * 2013-12-11 2018-11-02 Biogen Ma Inc. Spojevi biarila korisni za liječenje ljudskih bolesti u onkologiji, neurologiji i imunologiji
WO2015187088A1 (en) * 2014-06-04 2015-12-10 Thomas Helledays Stiftelse För Medicinsk Forskning Mth1 inhibitors for treatment of cancer
CN106794181A (zh) * 2014-06-04 2017-05-31 托马斯·黑勒戴药物研究基金会 用于治疗炎性和自身免疫性病况的mth1抑制剂
EP3154547B1 (en) 2014-06-13 2023-06-07 Yuma Therapeutics, Inc. Pyrimidine compounds and methods using the same
CR20180323A (es) 2015-11-20 2018-08-06 Idorsia Pharmaceuticals Ltd Derivados de indol n-sustituídos como moduladores de los receptores de pge2
WO2017142804A1 (en) * 2016-02-17 2017-08-24 Merck Sharp & Dohme Corp. Processes for the preparation of a bace inhibitor
US9840481B2 (en) 2016-03-22 2017-12-12 Merck Sharp & Dohme Corp. Allosteric modulators of nicotinic acetylcholine receptors
AU2017252276A1 (en) * 2016-04-18 2018-11-15 Celgene Quanticel Research, Inc. Therapeutic compounds
US10617680B2 (en) 2017-04-18 2020-04-14 Celgene Quanticel Research, Inc. Therapeutic compounds
AR111808A1 (es) 2017-05-18 2019-08-21 Idorsia Pharmaceuticals Ltd Derivados de pirimidina como moduladores del receptor de pge2
KR102612140B1 (ko) 2017-05-18 2023-12-08 이도르시아 파마슈티컬스 리미티드 피리미딘 유도체
EA201992676A1 (ru) 2017-05-18 2020-05-06 Идорсия Фармасьютиклз Лтд Фенильные производные в качестве модуляторов pge2 рецепторов
US11325899B2 (en) 2017-05-18 2022-05-10 Idorsia Pharmaceuticals Ltd Benzofurane and benzothiophene derivatives as PGE2 receptor modulators
CN109467538A (zh) 2017-09-07 2019-03-15 和记黄埔医药(上海)有限公司 环烯烃取代的杂芳环类化合物及其用途
WO2019133904A1 (en) * 2017-12-30 2019-07-04 Unity Biotechnology, Inc. Inhibitors of hsp90, pi3-kinase, proteasome, hdac, and p97 pathways for selective removal of senescent cells in the treatment of age related conditions
CA3091951A1 (en) 2018-03-01 2019-09-06 Thomas Helledays Stiftelse For Medicinsk Forskning Substituted benzodiazoles and use thereof in therapy
CN108997172B (zh) * 2018-08-08 2020-12-15 中国人民解放军总医院 抗肿瘤化合物
AR116635A1 (es) * 2018-10-15 2021-05-26 Servier Lab Proceso para la síntesis de derivados de piperazinil-etoxi-bromofenilo y su aplicación en la producción de compuestos que los contienen
US20240382482A1 (en) * 2021-03-17 2024-11-21 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors
GB202108249D0 (en) * 2021-06-09 2021-07-21 Univ Of Sussex Compounds
WO2024131742A1 (zh) * 2022-12-20 2024-06-27 深圳湾实验室 一种靶向usp1的小分子抑制剂及其应用
KR20250100559A (ko) * 2023-12-26 2025-07-03 (주)아이젠사이언스 신규한 유비퀴틴 특이적 펩티드 분해효소 1 저해제

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB681712A (en) 1949-09-14 1952-10-29 Burroughs Wellcome Co Improvements in or relating to therapeutically useful pyrimidine compounds
JPS4921148B1 (cg-RX-API-DMAC7.html) 1970-12-28 1974-05-30
JPS4921147B1 (cg-RX-API-DMAC7.html) 1970-12-28 1974-05-30
EP0210228A1 (en) 1985-02-05 1987-02-04 The Upjohn Company 4-substituted-6-aryl pyrimidine compounds
US6169086B1 (en) 1997-01-27 2001-01-02 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives
US6573377B1 (en) 1998-07-24 2003-06-03 Daiichi Pharmaceuticals Co., Ltd. Pyrazole derivatives and salts thereof
WO2002002093A2 (en) 2000-06-30 2002-01-10 Eli Lilly And Company Combination containing an antifolate and methylmalonic acid lowering agent
US20030208067A1 (en) 2001-05-30 2003-11-06 Cao Sheldon Xiaodong Inhibitors of protein kinase for the treatment of disease
HRP20040098B1 (en) 2001-08-13 2012-08-31 Janssen Pharmaceutica N.V. 2,4,5-TRlSUBSTITUTED THIAZOLYL DERIVATIVES AND THEIR ANTIINFLAMMATORY ACTIVITY
US7419984B2 (en) 2002-10-17 2008-09-02 Cell Therapeutics, Inc. Pyrimidines and uses thereof
WO2004080979A1 (en) 2003-03-14 2004-09-23 Lg Life Sciences Ltd. Novel 3-(2-amino-4-pyrimidinyl)-4-hydroxyphenyl ketone derivatives
US8084457B2 (en) * 2003-09-15 2011-12-27 Lead Discovery Center Gmbh Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
AU2005225471B2 (en) 2004-03-26 2011-05-12 Methylgene Inc. Inhibitors of histone deacetylase
WO2006078886A2 (en) 2005-01-18 2006-07-27 Irm Llc Compounds and compositions as wnt signaling pathway modulators
EP2066645A2 (en) * 2006-09-12 2009-06-10 UCB Pharma S.A. 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions
CL2008000467A1 (es) 2007-02-14 2008-08-22 Janssen Pharmaceutica Nv Compuestos derivados de 2-aminopirimidina, moduladores del receptor histamina h4; su procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno inflamatorio seleccionado de alegia, asma
EP2254415B1 (en) 2008-02-19 2013-01-23 Janssen Pharmaceutica, N.V. Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase
US8268846B2 (en) 2008-07-11 2012-09-18 Abbott Laboratories Amino heterocyclic linked pyrimidine derivatives
AR074199A1 (es) * 2008-11-20 2010-12-29 Glaxosmithkline Llc Compuesto de 6-(4-pirimidinil)-1h-indazol, composiciones farmaceuticas que lo comprenden y su uso para preparar un medicamento util para el tratamiento o disminucion de la gravedad del cancer.
CA2779681A1 (en) 2009-11-05 2011-05-12 Lexicon Pharmaceuticals, Inc. Tryptophan hydroxylase inhibitors for the treatment of cancer
CN102753168A (zh) 2010-02-10 2012-10-24 莱西肯医药有限公司 用于治疗转移性骨病的色氨酸羟化酶抑制剂
EP2651405A2 (en) 2010-12-14 2013-10-23 Electrophoretics Limited Casein kinase 1 (ck1 ) inhibitors
WO2013066839A2 (en) 2011-10-31 2013-05-10 Glaxosmithkline Llc Compounds and methods
GB201215502D0 (en) 2012-08-31 2012-10-17 Chalkiadakis Spyridon Medical use
PE20151412A1 (es) * 2012-11-27 2015-10-10 Thomas Helledays Stiftelse For Medicinsk Forskning Derivados de pirimidin-2,4-diamina para el tratamiento de cancer
CN106794181A (zh) * 2014-06-04 2017-05-31 托马斯·黑勒戴药物研究基金会 用于治疗炎性和自身免疫性病况的mth1抑制剂
CN104288170B (zh) 2014-10-22 2018-02-16 吉林大学 松果菊苷在抗肿瘤药物中的应用

Similar Documents

Publication Publication Date Title
RU2016151390A (ru) Ингибиторы мтн1 для лечения воспалительных и аутоиммунных заболеваний
Tanaka et al. Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy) methyl]-6-(phenylthio) thymine (HEPT) as potent and selective anti-HIV-1 agents
US20080182845A1 (en) Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection
RU2014128307A (ru) Пиррольное производное шестичленного гетероарильного кольца, способ его получения и его медицинское применение
JP6218260B2 (ja) Jak阻害剤としてのアミノピリミジニル化合物
RU2013158933A (ru) Новые модуляторы иммунной системы родственные заявки
JP2020510010A5 (cg-RX-API-DMAC7.html)
JP2007517044A5 (cg-RX-API-DMAC7.html)
JP2006143737A5 (cg-RX-API-DMAC7.html)
JP2020510015A5 (cg-RX-API-DMAC7.html)
JP2017513955A5 (cg-RX-API-DMAC7.html)
JP2017125037A (ja) イミダゾピロリジノン化合物
JP2018519302A5 (cg-RX-API-DMAC7.html)
CN110573500A (zh) N-(氮杂芳基)环内酰胺-1-甲酰胺衍生物及其制备方法和应用
JP2003535828A5 (cg-RX-API-DMAC7.html)
KR950704320A (ko) Crf 길항제로서의 피롤로피리미딘(pyrrolopyrimidines as crf antagonists)
JP2005507380A5 (cg-RX-API-DMAC7.html)
AU2015243110A1 (en) Tyrosine kinase inhibitors
RU2015106787A (ru) Замещенные пирролы, активные в качестве ингибиторов киназ
US20160175316A1 (en) Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection
JP2009526849A5 (cg-RX-API-DMAC7.html)
RU2009103810A (ru) Новые соединения
JP2023533915A (ja) Hivの治療のためのカプシド阻害剤
CA2648036A1 (en) Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor
RU2007108861A (ru) Трифтометилзамещенные бензамиды в качестве ингибиторов киназ